2000 myeloma patients to help shape future cancer care

NCT ID NCT04888039

Recruiting now Knowledge-focused Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 2000 people with multiple myeloma in the West-Occitanie region of France to see how they are treated in real life and how their quality of life changes over time. Researchers will collect data from medical records and ask patients to fill out questionnaires about their well-being. The goal is to learn what treatments work best outside of clinical trials and improve care for all patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors understand which treatments work best in everyday patients and improve quality of life for people with multiple myeloma.
What could go wrong: This is an observational study, not a treatment trial. It collects data without testing new drugs, so it won't directly change care. Results may take years and might not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE MYELOMA

Contacts and locations

Locations

IUCT-Oncopole - Toulouse University Hospital
RECRUITING

Toulouse, West-Occitanie, 31059, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.